The Global Molecularimaging Market, by Technology (Gamma Camera, SPECT, PET, Magnetic ResonanceSpectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), byApplication (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder,Lung Disorder, Bone Disorder, and Others), by End User (Hospital, DiagnosticImaging Centers, and Others), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3.8 billion in2017, and is projected to exhibit a CAGR of 8.1% over the forecast period (2018- 2026).
Defining disease processes basedon their molecular and cellular changes and advances in genomics offer promisefor earlier disease detection and molecular prevention in some cases. The fieldof molecular imaging is adopting these advances and is using varioustechnologies to study disease states and physiology. For instance, opticalmethods, such as variations of fluorescence imaging, can resolve tissuemicrostructures or target specific cells using molecular probes. Massspectrometry offers a new modality for molecular imaging in image-guidedsurgery by providing detailed information of the chemical makeup of surgicaltissue without the need for molecular probes. Molecular imaging is generallyused to improve the diagnosis and treatment of lung cancer. In breast cancer,molecular imaging is used to minimize the removal of axillary lymph nodes bydetermining which nodes are most likely to contain cancer cells. For manygastrointestinal cancers, PET-CT, a molecular imaging technology, is able toidentify cancer invasion in the body and assess patient response tochemotherapy. It is also useful in colorectal cancer diagnosis and treatment byproviding useful information that directly affects treatment options.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2191
Browse 27 Market Data Tables and31 Figures spread through 180 Pages and in-depth TOC on "Molecular ImagingMarket, by Technology (Gamma Camera, SPECT, PET, Magnetic ResonanceSpectroscopy, Optical Imaging, and Molecular Ultrasound Imaging), byApplication (Cancer, Heart Disease, Brain Disorder, Gastrointestinal Disorder,Lung Disorder, Bone Disorder, and Others), by End User (Hospital, DiagnosticImaging Centers, and Others), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
Manufacturers are focused onresearch and development to integrate advanced medical technologies for invitro diagnosis. For instance, in 2014, Philips Healthcare received the U.S.FDA approval for spectral imaging system (IQon Spectral CT). The IQon SpectralCT is a leading, new, high standard for medical imaging. As per the study conductedby Radiological Society of North America, in 2013, Philips IQon Spectral CTsystem exhibited enhanced diagnosis in up to 70% cases as compared toconventional imaging methods. With rapid technological advancements, targetedtherapy, presymptomatic detection, and personalized medicine are possible infuture with the use multimodal molecular imaging. Moreover, researchers areusing molecular imaging to identify the strategies for developing new drugs andto design clinical trials to test their effectiveness. Information provided bymolecular imaging technologies has the potential to accelerate the drugdevelopment and approval process by making it less expensive and moreeffective.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/molecular-imaging-market-2191
Key Takeaways of the MolecularImaging Market:
The global molecular imagingmarket is expected to expand at a CAGR of 8.1% during the forecast period(2018–2026), owing to increasing demand for early disease detection coupledwith rising prevalence of cancer and other chronic diseases.
Among technology, the SPECTsegment is expected to generate significant revenue in 2018, owing to advancedradionuclide molecular imaging techniques that are able to evaluate biochemicalchanges and levels of molecular targets within a living subject.
Major players operating in theglobal molecular imaging market include Carestream Health, Fujifilm HoldingsCorporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, PhilipsHealthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical SystemsCorporation.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2191
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
